This Biotech Stock Hits Buy Point After Earnings Burst
investors.com/research/tgtx-stock-tg-therapeutics-multiple-sclerosis-biotech/?src=A00220
Multiple sclerosis biotech firm TG Therapeutics (TGTX) is Thursday's pick for IBD 50 Growth Stocks To Watch. TGTX stock jumped Thursday and broke out of an irregular base and is in a buy zone. Shares of TG Therapeutics bolted higher after the company topped fourth-quarter sales…
This story appeared on investors.com, 2025-03-06 17:22:27.